Why I’d buy these 2 FTSE 100 defensive shares today

I think holding FTSE 100 defensives in my investing portfolio is always a good idea. It can keep me safe in times of economic downturns. 

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

It is not like I am expecting a recession or even a slowdown. But I do think that it is a good idea to allocate a proportion of my stock investing portfolio to FTSE 100 defensives or safe shares. 

Why buy FTSE 100 defensives

The reason is that economic growth happens in cycles. This means that we should always be prepared for the next phase, and that includes downturns. Moreover, sometimes these come about unpredictably, as we saw last year. 

The FTSE 100 index has a number of high-quality defensives to choose from, ranging across sectors from healthcare to technology, that I can choose from today. Here are two of them:

#1. Hikma Pharmaceuticals: robust health

After touching all-time highs in October, drug manufacturer Hikma Pharmaceuticals (LSE: HIK) has now seen a share price fall of 18%. But going by its results, I think that the manufacturer of Covid-19 medication is due for another share price rally. 

For the full year 2020, the company saw a 23% increase in operating profit and its revenues increased as well. It expects to continue making progress in 2021 too. 

A small positive in buying the share is also its dividend payouts. It has a yield of 1.6%, but it is increasing its dividends. 

The flipside here is that its reported earnings per share (EPS) fell by 9% in the year. To me, this makes further increases in dividends unlikely.

Also, I think this FTSE 100 share could take its time to start rising from here. Defensives or safe stocks are less attractive to investors now, as the economic outlook improves. For the long-term, though, it is a buy for me. 

#2. Unilever: back to market crash levels

The consumer staples’ giant Unilever (LSE: ULVR) saw a sharp share price fall early last month after it reported an underwhelming set of financials. Both the company’s revenues and profits fell.

Going by the company’s past resilience however, I see this more as a blip than the start of a trend. This is even more so now that the economy will recover in 2021. 

Importantly, for income investors the 1% decline in its EPS was disappointing too. The Unilever stock did not have a high dividend yield in the past. But after the hit to dividends across the board in 2020, it does look relatively more attractive from the income perspective. It has a yield of 3.6% now, which I think is alright compared to many others. 

The risk to Unilever is that of a slow recovery or if cost pressures mount.

Another poor year for the UK’s consumer giant will tell further on its share price. Investors have made their disappointment with the latest results amply clear already. In the weeks following the results, its share price dropped to the levels seen during last year’s stock market crash. 

The FTSE 100 share has started recovering since, and I am optimistic about its prospects on balance. 

Manika Premsingh has no position in any of the shares mentioned. The Motley Fool UK has recommended Hikma Pharmaceuticals and Unilever. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Female student sitting at the steps and using laptop
Investing Articles

UK stocks: the contrarian choice for 2026

UK stocks aren’t the consensus choice for investors at the moment. But some smart money managers who are looking to…

Read more »

Investing Articles

Down 20% in 2025, shares in this under-the-radar UK defence tech firm could be set for a strong 2026

Cohort shares are down 20% this year, but NATO spending increases could offer UK investors a huge potential opportunity going…

Read more »

Young Caucasian woman with pink her studying from her laptop screen
Investing Articles

New to investing? Here’s Warren Buffett’s strategy for starting from scratch

Warren Buffett says he could find opportunities to earn a 50% annual return in the stock market if he was…

Read more »

Investing Articles

Can the sensational Barclays share price do it all over again in 2026?

Harvey Jones is blown away by what the Barclays share price has been doing lately. Now he looks at whether…

Read more »

Investing Articles

Prediction: in 2026 mega-cheap Diageo shares could turn £10,000 into…

Diageo shares have been burning wealth lately but Harvey Jones says long-suffering investors in the FTSE 100 stock may get…

Read more »

Investing Articles

This overlooked FTSE 100 share massively outperformed Tesla over 5 years!

Tesla has been a great long-term investment, but this lesser-known FTSE 100 company would have been an even better one.

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

I’m backing these 3 value stocks to the hilt – will they rocket in 2026?

Harvey Jones has bought these three FTSE 100 value stocks on three occasions lately, averaging down every time they fall.…

Read more »

Investing Articles

Can the barnstorming Tesco share price do it all over again in 2026?

Harvey Jones is blown away by just how well the Tesco share price has done lately, and asks whether the…

Read more »